A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis
Condition(s):Scleroderma, Systemic; Skin Sclerosis; Lung Fibrosis; Autoimmune Diseases; Collagen DiseasesLast Updated:February 18, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Scleroderma, Systemic; Skin Sclerosis; Lung Fibrosis; Autoimmune Diseases; Collagen DiseasesLast Updated:February 18, 2020Completed
Condition(s):Systemic SclerosisLast Updated:March 9, 2020Completed
Condition(s):Gastroesophageal Reflux Disease (GERD)Last Updated:June 2, 2014Completed
Condition(s):PhotoagingLast Updated:October 19, 2023Completed
Condition(s):Fibrodysplasia Ossificans Progressiva (FOP)Last Updated:February 16, 2024Recruiting
Condition(s):Colitis, UlcerativeLast Updated:April 27, 2022Terminated
Condition(s):Sleep Initiation and Maintenance Disorders; Sleep DisordersLast Updated:August 20, 2014Completed
Condition(s):HIVLast Updated:November 3, 2022Completed
Condition(s):Multiple SclerosisLast Updated:June 25, 2012Completed
Condition(s):Sleep Initiation and Maintenance DisordersLast Updated:August 20, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.